Tandem Diabetes Care, Inc. (TNDM)’s director Dick Allen Invested in 60,000 Shares of the Company; 7 Analysts Are Bullish Inchcape plc (LON:INCH) Last Week

The director of Tandem Diabetes Care Inc and company’s insider Dick Allen acquired 60,000 shares of the company based on the average price of stock which is $2.0 a share. The mentioned shares are valued at $120,000 US Dollars. Dick Allen presently has 0.76% of the company’s total market cap with ownership of 77,058 shares. 

Among 12 analysts covering Inchcape PLC (LON:INCH), 7 have Buy rating, 1 Sell and 4 Hold. Therefore 58% are positive. Inchcape PLC had 122 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Neutral” rating by BNP Paribas given on Monday, September 12. Liberum Capital maintained the stock with “Hold” rating in Friday, January 15 report. The firm has “Buy” rating given on Monday, August 1 by Citigroup. Liberum Capital maintained Inchcape plc (LON:INCH) on Monday, October 19 with “Hold” rating. The stock has “Hold” rating by Liberum Capital on Monday, January 11. The stock of Inchcape plc (LON:INCH) has “Overweight” rating given on Tuesday, July 28 by JP Morgan. The rating was maintained by HSBC with “Buy” on Monday, April 24. As per Wednesday, March 16, the company rating was maintained by Numis Securities. The rating was maintained by Citigroup on Tuesday, March 7 with “Buy”. Numis Securities maintained Inchcape plc (LON:INCH) on Friday, July 29 with “Hold” rating. See Inchcape plc (LON:INCH) latest ratings:

01/02/2018 Broker: Barclays Capital Rating: Underweight New Target: GBX 695.00 Initiates Starts
16/01/2018 Broker: Berenberg Rating: Hold Old Target: GBX 860.00 New Target: GBX 825.00 Downgrade
02/01/2018 Broker: Deutsche Bank Rating: Buy Old Target: GBX 910.00 New Target: GBX 920.00 Maintain
08/12/2017 Broker: Deutsche Bank Rating: Buy Old Target: GBX 925.00 New Target: GBX 910.00 Maintain
27/10/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 920.00 New Target: GBX 920.00 Maintain
10/10/2017 Broker: Deutsche Bank Rating: Buy Old Target: GBX 935.00 New Target: GBX 935.00 Maintain
08/09/2017 Broker: Deutsche Bank Rating: Buy Old Target: GBX 935.00 New Target: GBX 935.00 Maintain

The stock increased 0.29% or GBX 2 during the last trading session, reaching GBX 694.5. About 90,017 shares traded. Inchcape plc (LON:INCH) has 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Inchcape plc operates as an automotive distributor and retailer in the premium and luxury automotive sectors. The company has market cap of 2.88 billion GBP. The firm sells and retails new and used cars of various brands. It has a 14.53 P/E ratio. It also provides after sales servicing and parts; and vehicle finance and insurance services and products.

Investors sentiment increased to 0.59 in Q3 2017. Its up 0.04, from 0.55 in 2017Q2. It improved, as 24 investors sold Tandem Diabetes Care, Inc. shares while 8 reduced holdings. 10 funds opened positions while 9 raised stakes. 7.03 million shares or 59.85% less from 17.51 million shares in 2017Q2 were reported. Wells Fargo And Mn reported 7,789 shares stake. Stifel Financial accumulated 0% or 14,750 shares. Dowling & Yahnke Limited Liability Com stated it has 0% in Tandem Diabetes Care, Inc. (NASDAQ:TNDM). Federated Investors Pa invested in 0% or 4,578 shares. Virtu Ltd Limited Liability Company reported 99,567 shares. Pnc Ser Group Inc has invested 0% in Tandem Diabetes Care, Inc. (NASDAQ:TNDM). Germany-based Deutsche Bank & Trust Ag has invested 0% in Tandem Diabetes Care, Inc. (NASDAQ:TNDM). Citigroup reported 10,000 shares stake. 58,361 are held by First Mercantile Trust. Royal National Bank & Trust Of Canada owns 2,816 shares or 0% of their US portfolio. Weiss Multi owns 20,000 shares. Meeder Asset Incorporated invested in 0% or 2,589 shares. 50,678 were reported by Northern. Prelude Management Ltd Liability Co reported 772 shares or 0% of all its holdings. Renaissance Tech Limited Company stated it has 245,300 shares.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company has market cap of $24.59 million. The company's flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its disposable insulin cartridge, and an infusion set. It currently has negative earnings. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; and t:slim G4 insulin delivery system, a touch-screen pump with an integrated CGM system.

The stock increased 0.83% or $0.02 during the last trading session, reaching $2.43. About 889,049 shares traded or 51.60% up from the average. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has declined 86.78% since February 14, 2017 and is downtrending. It has underperformed by 103.48% the S&P500.

Among 9 analysts covering Tandem Diabetes Care (NASDAQ:TNDM), 3 have Buy rating, 1 Sell and 5 Hold. Therefore 33% are positive. Tandem Diabetes Care has $19.0 highest and $1.5 lowest target. $7.25’s average target is 198.35% above currents $2.43 stock price. Tandem Diabetes Care had 20 analyst reports since August 5, 2015 according to SRatingsIntel. Zacks upgraded the stock to “Sell” rating in Wednesday, August 5 report. The stock of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has “Buy” rating given on Wednesday, November 2 by Feltl & Co. Wedbush maintained it with “Outperform” rating and $11 target in Wednesday, November 2 report. The rating was maintained by Deutsche Bank on Monday, August 10 with “Buy”. The firm has “Hold” rating given on Friday, September 4 by Zacks. Zacks upgraded the stock to “Hold” rating in Saturday, August 22 report. The stock has “Underperform” rating by Bank of America on Monday, November 20. Deutsche Bank maintained the shares of TNDM in report on Wednesday, November 2 with “Buy” rating. On Thursday, October 5 the stock rating was maintained by Piper Jaffray with “Hold”. The firm has “Buy” rating by Zacks given on Friday, August 28.